BlackRock Institutional Trust’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$265K Hold
1
﹤0.01% 3556
2016
Q3
$310K Hold
1
﹤0.01% 3568
2016
Q2
$282K Hold
1
﹤0.01% 3590
2016
Q1
$726K Hold
1
﹤0.01% 3373
2015
Q4
$998K Hold
1
﹤0.01% 3325
2015
Q3
$1.11M Hold
1
﹤0.01% 3309
2015
Q2
$1.78M Hold
1
﹤0.01% 3164
2015
Q1
$2.94M Hold
1
﹤0.01% 2947
2014
Q4
$2.22M Hold
1
﹤0.01% 3057
2014
Q3
$2.26M Hold
1
﹤0.01% 3026
2014
Q2
$3.09M Buy
+1
New +$4.7M ﹤0.01% 2998
2014
Q1
Hold
0
3751

Other funds holding PALI

BlackRock Institutional Trust's PALI Position: Q4 2016 in Review

BlackRock Institutional Trust held its Palisade Bio (PALI) position steady in Q4 2016 at 1 share worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #3556.

BlackRock Institutional Trust first reported a position in PALI in Q2 2014 and has held it in 11 quarters since. The position peaked at $3.09M in Q2 2014. 3 funds tracked by Wall St. Rank hold PALI as of Q4 2016.

  • BlackRock Institutional Trust held 1 share of Palisade Bio worth $265K as of Q4 2016.
  • BlackRock Institutional Trust left its Palisade Bio share count unchanged in Q4 2016.
  • Palisade Bio made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3556 holding.
  • BlackRock Institutional Trust first reported a position in Palisade Bio in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Institutional Trust's Palisade Bio position peaked at $3.09M in Q2 2014.
  • 3 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.